Abstract:Objective To explore the value of heart failure ultrasound index combined with serum galectin-3 (Gal-3) and cyclophilin A in the diagnosis of chronic heart failure (CHF). Methods Totally 312 chronic heart failure (CHF) patients (observation group) admitted from January 2015 to January 2018 were classified into class I group, class II group, class III group, and class IV group according to NHYA classification, and were divided into contraction type group and diastolic type group according to left ventricular ejection fraction. Sixty healthy people examined in the same period were selected as control group. The ultrasound index of heart failure combined with the serum levels of Gal-3 and cyclophilin A were measured and their correlation with cardiac function was analyzed. Results The difference in serum Gal-3, cyclophilin A, and heart rate ultrasound index between the control group and class I group, class II group, class III group, and class IV group was statistically significant (P < 0.05). And the grade was higher, the leves of Gal-3, cyclophilin A, and the heart rate ultrasound index were higher. Serum Gal-3, cyclophilin A, and heart failure ultrasound index in patients with systolic heart failure were higher than those in patients with diastolic heart failure (P < 0.05). Serum Gal-3, cyclophilin A, heart failure ultrasound index were significantly negatively correlated with LVEF (r =-0.635, -0.622, -0.628, all P < 0.05), and positively correlated with heart function NHYA grading (r =0.745, 0.834, 0.867, P < 0.05). Conclusions The detection of heart failure ultrasound index combined with serum Gal-3 and cyclophilin A can further improve the clinical diagnosis of chronic heart failure, and it can be used as an important indicator of cardiac function assessment.